Ceflar S 500mg/250mg Injection
Marketer
Kevlar Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceflar S 500mg/250mg Injection
Ceflar S 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects require immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) necessitate prompt medical help. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Primary Ingredients of Ceflar S 500mg/250mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Ceflar S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceflar S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceflar S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceflar S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceflar S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, the components of Ceflar S 500mg/250mg Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Ceftriaxone, thus maximizing its antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Ceflar S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceflar S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials using animal models have revealed minimal or no harmful effects on fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
The administration of Ceflar S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's course of treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceflar S 500mg/250mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Operation of vehicles should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceflar S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Ceflar S 500mg/250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Ceflar S 500mg/250mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceflar S 500mg/250mg Injection :
Should you forget a scheduled dose of Ceflar S 500mg/250mg Injection, seek medical advice.
Facts to Know About Ceflar S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently